Announced Thu, 25 Jun · 13:09 IST
Trading window closed from July 1 for Q1 results
Compliance View source PDF
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹612.15
prior close
₹608.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2+0.1+0.0+2.2+1.8+3.2+4.1+2.7+6.7+8.7+10.3——
Up moveDown movePending
AI summary
Akums Drugs has closed its trading window from July 1, 2026 until 48 hours after the declaration of unaudited financial results for Q1 ending June 30, 2026. This is a routine compliance measure under SEBI insider trading rules and applies to designated persons and their immediate relatives. The board meeting date to approve the results will be announced separately.
Likely market impact
Routine compliance filing; signals Q1 FY27 results are upcoming. No direct impact on stock price.